Rituximab-induced autoimmune hepatitis: A case study and literature review

Polymnia Galiatsatos1, Sarit Assouline2, Adrian Gologan3

  • 1Division of Gastroenterology, Department of Medicine, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.

Canadian Liver Journal
|August 22, 2022
PubMed
Summary

This study reports a rare case of autoimmune-type drug-induced liver injury following rituximab treatment for MALT lymphoma. It highlights a previously undocumented adverse effect of this common immunotherapy.